Gene therapy successful! Just one customer?

Glybera, a gene therapy for a rare disease called lipoprotein lipase deficiency, contains trillions of viruses harboring correct copies of the lipoprotein lipase gene. The first treatment, administered in September 2015, was successful and the patient now is living normally. But the drug is failing because of government regulations and a$1 million insurance price tag. Read the whole thing.